Cannabis Legalization

Ontario cuts essential workplaces list to limit COVID-19 spread

The Ontario government ordered more workplaces closed — including bricks-and-mortar cannabis shops and some industrial construction sites — in a stepped up campaign to limit the spread of the coronavirus.

“We can’t stop now,” Premier Doug Ford said Friday. “There’s 1,600 people out there who need us to do everything we can in the next 30 days to help save them.”

Public health COVID-19 models show that many people could die by the end of the month unless more stringent social distancing measures are taken.

A new list of businesses were ordered to arrange for staff to work remotely or shutter their operations by 11:59 p.m. Saturday.

“All industrial construction except critical industrial projects will stop,” Ford said. “Only necessary infrastructure projects like hospitals and transporation will continue.”

While no new residential construction projects will be allowed to break ground, those already under construction will continue.

Ford said the vast majority of Ontario workers have now been told to stay home.

“We’ve had to shut down most of our economy,” he said.

Businesses that remain open include those that supply essential services, supermarkets, restaurants for take-out or delivery, alcohol stores like the LCBO, pharmacies, gas stations, funeral services, vets for urgent care only, hotels and cheque cashing services.

Insurance, telecommunications, transportation and maintenance services can also continue.

Stores that sell hardware, vehicle parts, pet and animal supplies, office goods and computer products will only be allowed to provide alternative methods of sale such as curb side pick-up or delivery.

David Clement, of the Consumer Choice Center (CCC), said it was a shame the Ford government is shutting down cannabis retailers.

“This move does nothing but embolden the black market, who will obviously continue to meet consumer demand,” he said in a statement.

The online option for buying from the Ontario Cannabis Store remains available.

Ford said he’s acting on the advice of his Chief Medical Officer of Health in shutting down more sectors of the economy.

However, he said people will still need to access their medication and food.

“As soon as you take that food off the shelves and close down retail you get … anarchy,” Ford said. “You get civil disobedience — people are going to do what they have to do to feed their family — and we don’t want to go to that point.”

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Medical homegrowers are supplying the illicit market. Here’s why more policing isn’t the answer

The Consumer Choice Center’s David Clement explains how easing cannabis regulations could help personal growers enter the legal space

In less than two years, cannabis has gone from an illegal product to an essential service during a pandemic. But despite reports of increased sales as consumers stockpile for COVID-19 lockdowns, Canada’s cannabis market is struggling.

We kicked off this year with declining stock prices for licensed cultviators,
stagnant sales and rumours of a pending insolvency crisis for many mediumsized companies. The current coronavirus crisis could make this trend worse as global markets plummet.

There are a lot of reasons why Canada’s cannabis industry stumbled out of
the gate. Poor retail access, specifically Ontario; over-regulation and high tax rates. And establishing brand awareness in a market that prevents even the most modest forms of advertising and branding is challenging.

But there’s an additional factor at play: The program for growing medical
cannabis for personal use is undermining the legal market and fueling the
illicit market. Far more cannabis is being grown than medical cannabis consumers require — and some of that cannabis is being sold on the illicit
market. I’d like to propose a few potential solutions.

Breaking down the numbers

As a result of several Supreme Court rulings, medical cannabis consumers
have the constitutional right to grow their own medicine and can apply to do so through Health Canada.

The latest figures show that there are 28,869 Canadians who have their determined by Health Canada. Medical consumers are generally authorized
to consume between five and 60 grams of cannabis per day.

We don’t have national data, but general trends can be extrapolated from
provincial data. Via an access to information request, the average permit holder in Manitoba is authorized to consume 18 g/day, which entitles them to grow 88 indoor plants per year.

Quebec’s data is nearly double that of Manitoba: A 30 g/day average entitles
a medical consumer to grow 146 indoor cannabis plants each year. If we take provincial figures and forecast them on a national scale, permit
holders are growing a staggering amount of cannabis. Each indoor plant can produce between 250-600 grams per harvest, of which there are usually
three per year. One outdoor plant, with only one harvest, can yield as much
as 1.8 kg/year. A conservative estimate? The average Manitoba permit
holder could grow up to 66,000 grams (or 66 kg) of cannabis annually.

Rather than trying to arrest their way out of the problem, the government should focus on transitioning permit holder growers into the legal market

Applying that math to all Canadian permit holders would mean that in 2019, they grew an estimated 1.9 million kilograms of cannabis — approximately 158,000 kg — per month. Compare that to the legal recreational industry’s output: In August of 2019, the total amount of all legal recreational cannabis available for sale was 61,000 kg. Medical permit growers in Canada could be growing 2.5 times more cannabis than is legally available for sale in the recreational market. If Quebec’s figures are more representative of the national average, these growers would be growing 4.5 times more cannabis than is legally available.

Permit holders are growing more than then they need for personal
consumption. At 18 grams per day, a permit holder would need 6,570 grams
annually, while being permitted to produce more than 66,000 grams a year.
So where does most of the excess cannabis end up? The illicit market: York
Region Police’s recent bust showed that criminal networks were abusing the Health Canada permit process. The same thing happened
recently in Alberta, where a biker gang bust showed that illicit cannabis was grown by a Health Canada permit holder.

Either organized crime is taking advantage of Health Canada’s process, or
permit holders are enticed to sell their excess cannabis to criminals so it can be resold. This is part of the reason why the legal recreational market hasn’t truly materialized.

Increased policing isn’t the answer

But the government shouldn’t target legitimate permit holders. Doing so
would violate their constitutional rights, and would be exceptionally cruel
given how marginalized this group has historically been. Rather than trying
to arrest their way out of the problem, the government should focus on
transitioning permit holder growers into the legal market. A first step for this transition would be to restructure the regulations for growing cannabis.

Right now, licensed producers (LPs) have to comply with nearly pharmagrade regulations. Instead, they should more closely resemble food grade production standards. This would give medical permit-holders a realistic shot at earning a micro-cultivator licence and entering the legal market. It would also benefit existing producers by reducing compliance costs.

There are a few onerous barriers permit holders have to jump over that could be eased to help transition them into the legal space: The security clearance process is one, but we could also be easing facility regulations, reducing licensing fees, reducing the batch test minimum of 100 g/batch, or fast tracking the licensing and renovation amendment timelines. This would clear a path for these growers to enter the legal market and incentivize them away from the illicit market.

To say Canada’s legalization process thus far has been messy would be an
understatement. At almost every turn the government has over-regulated
the legal market, which is what keeps the illicit market thriving. Easing these heavy-handed regulations could bring more growers into the legal sphere and make for a more consumer-friendly market all around.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

BC should allow online recreational cannabis sales to protect consumers and staff

British Columbians should be allowed the same socially distant transaction options as other provinces

Despite reports of “click-and-collect” services coming to B.C. retail, a recent provincial policy directive still requires customers to go in-store to pay for and pick up their weed.

This new directive falls short of online sales and delivery options available in provinces including Alberta, Saskatchewan and Ontario.

Providing these options would allow B.C. residents, who currently face the country’s highest number of COVID-19 infections, to reduce non-essential physical transactions that have the potential to spread the disease.

Tuesday afternoon’s update from provincial health officer Dr. Bonnie Henry showed B.C. pulling ahead of Ontario for the first time with a total of 617 confirmed cases, compared to Ontario’s 572. For reference, the population of Ontario is nearly three times that of B.C.

International advocacy group the Consumer Choice Center, who recently called for all provinces to legalize same-day delivery, said such policies would have the added benefit of reducing illicit sales.

Currently, B.C.’s provincial wholesaler holds a monopoly on online recreational cannabis sales. “BC Cannabis Stores: the only place to shop non-medical cannabis online in BC,” reads a slogan on the homepage of its website.

Late Friday, British Columbia’s Liquor and Cannabis Regulation Branch (LCRB) authorized private cannabis retailers to offer non-medical cannabis product reservations online or by phone.

However, the guidance says that reserved products must be paid for and picked up in store.

The move comes after multiple calls from B.C. retailers for the province to allow for cannabis delivery and “click-and-collect” services that are offered in other Canadian provinces.

“It’s hard for us when we don’t have an option,” Muse Cannabis manager Frida Hallgren told Mugglehead in an interview last week. “At times like this it would have been very useful to have a delivery system.”

Unclear how product reservations support social distancing

The term click-and-collect is used to describe retail services where customers buy a product online and then come to collect it, either in-store or at the curbside.

The demand for brick-and-mortar alternatives has expanded rapidly as citizens have been asked, and now ordered, to practice social distancing measures in an effort to stop the spread of COVID-19.

With its new expanded emergency powers, the City of Vancouver can now fine businesses up to $50,000 and individuals $1,000 for violating social distancing guidelines.

Muse Cannabis Granville Street Vancouver
Unlike other major provinces, B.C. consumers still need to pay for their weed in-store. Photo by Nick Laba

It’s unclear how the LCRB’s new policy would work to decrease potentially risky social interactions if customers have to meet staff in-store to buy cannabis products.

As its explanation, the branch said no policy direction on non-medical cannabis product reservations was provided previously.

“This policy change now allows licensees to offer reservations of non-medical cannabis products available in their store to customers via their website or by telephone,” it said. “Existing requirements for licensee websites remain and licensees are prohibited from selling non-medical cannabis products online or by telephone. However, licensees may continue online sales of cannabis accessories and gift cards.”

Mugglehead reached out to the B.C. Attorney General’s office on Monday morning about why online sales are not being allowed, and is waiting for comment.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Group calls on provinces to ‘immediately remove barriers’ to same-day weed delivery

Delivery would make life easier on Canadians during coronavirus outbreak while helping stave off black market.

The Consumer Choice Center (CCC) wants the rest of Canada’s provinces to join Saskatchewan and Manitoba in allowing the same-day delivery of cannabis.

Self-described champions of lifestyle freedom and innovation, the group noted that weed should not be excluded from the extensive list of everyday items consumers can have brought to their front door, especially in the time of COVID-19.

“Consumers can order household products, food and alcohol for same-day delivery,” said David Clement, North American affairs manager for the CCC. “It is silly to prohibit same-day cannabis delivery from licensed retailers,” Clement said.

“With the exception of Manitoba and Saskatchewan, cannabis consumers are left waiting days for Canada Post to deliver online orders. Provincial governments should immediately remove the legal barriers for same-day delivery from licensed retailers.”

After legalization, Saskatchewan and Manitoba quickly emerged as testing grounds for cannabis delivery services, thanks to their relatively liberal retail regimes, which allow private actors to operate online stores.

The result of those policies — which differ from rules in Ontario, Quebec, B.C. and Alberta, where online cannabis stores are controlled by the province — has been a flurry of cannabis start-ups, including Super Anytime Inc., Pineapple Express Delivery Inc. and Prairie Records that offer same-day delivery to recreational cannabis consumers.

The Ontario Cannabis Store has been slowly testing same-day delivery in the province, but it is currently only available to select postal codes in the Greater Toronto Area, Hamilton, Guelph and Waterloo.

But the time has come to integrate the service countrywide, Clement argued. “Allowing for same-day delivery will help cannabis consumers during the COVID-19 outbreak, but it will also help combat the black market in the long run,” he said.

“There are a variety of illegal online options for same-day delivery. Allowing for licensed retailers to compete will make the legal market more attractive, and could help consumers switch from the black market to the legal market,” he added.

The consumer advocacy group has been critical of government regulation of cannabis in the past, slamming package regulations as being “heavy-handed” and arguing that Canadian consumers have paid the price for the government’s inability to understand the drug.

Originally published here.

A Push for Smart Regulation of CBD

Encourage competition, safety, medical facts and eradication of the black market

ARLINGTON, Va. — Flashy display cases, provocative brand names and lists of health benefits have elevated cannabidiol (CBD), a nonintoxicating compound found in cannabis, to be one of the hottest product trends today.

Whether it be for health, pets or beauty care, the use cases of CBD are becoming mainstream. It’s not uncommon to hear stories of consumers using CBD to alleviate pain in their joints, reduce anxiety and improve sleep.

Retail Revolution

The revolution is already here, and it arrived in a fury. The only guardrails came with the legalization of industrial hemp in the 2018 Farm Bill. That law created a legal distinction between a relative of cannabis without THC (tetrahydrocannabinol)—commonly known as hemp—and THC cannabis, which remains classified as marijuana and is still illegal under the Controlled Substances Act.

That law was a huge boost for farmers, entrepreneurs and consumers in the CBD space. And while it answered many questions, it sparked many more that will take time and deliberation to resolve: Who tests the actual CBD content of these products? Where are these products sourced? Which benefits and health claims are legitimate?

The U.S. Food and Drug Administration (FDA) has been running to catch up. It has so far focused on bogus health claims made by producers. Meanwhile, the FDA still maintains that food products containing CBD are illegal, despite their widespread availability in stores in practically every state and no real method of enforcement.

In May 2019, the FDA invited scientists, entrepreneurs and consumers to participate in a public hearing. Following statements and presentations from dozens of attendees, including myself, the FDA remains uncertain of what consumers and c-store owners looking to try or sell CBD products need to do to comply with the law.

The FDA is awaiting further instructions from lawmakers in Congress, who are currently floating myriad proposals to deal with cannabis. The latest would classify CBD as a health supplement, exempting it from more stringent regulation and allowing broader distribution in food and drinks.

Core Issues

Apart from that, there are still many gaps to fill. Considering many store owners are currently selling these products, it’s important that both sellers and consumers are aware of the core issues that should be addressed by the FDA and regulators.

In that May hearing, my group, the Consumer Choice Center, presented the following suggestions to the FDA if it wishes to implement smart regulation of CBD. Smart regulation would encourage competition, safety, medical facts and eradication of the black market.

The suggestions are:

  • Develop clear labeling standards, including the percentage of CBD and THC.
  • Allow free advertising and branding.
  • Allow stated health claims and benefits.
  • Embrace harm reduction by allowing CBD products in food, drinks, oils and topical products that do not require combustion.

We hope the FDA takes these points seriously and that these principles are followed by the industry as well.

What should the CBD-curious c-store professional do if they want to dive into CBD products?

  • Maintain a high standard for the products they source.
  • Choose only products with clear labeling and reasonable health claims.
  • Read the included fact sheets and materials that come with orders from reputable CBD firms.
  • Use independent testing services to check the levels of CBD and other compounds.

Entrepreneurs and consumers can work together today to ensure a competitive market with safe, beneficial and exciting innovations that will provide value to everyone.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Level the cannabis ingesting field by legalizing consumption in commercial spaces

Basements and garages were once the only places you could consume cannabis in peace. But now, if the provincial consultation process advances the interests of consumers, millions of Ontario residents will be able to try some forms of the newly legal substance in licensed commercial settings, including bars, lounges and outdoor festivals. One caveat to this development is that the province will not revise the Smoke Free Ontario Act, so only ingesting cannabis products, not smoking them, will be considered for enclosed public spaces.

By significantly increasing consumer choice, moving forward with commercial consumption would be a big win for cannabis consumers in Ontario. This move would bring cannabis regulation closer to alcohol regulation, a big improvement over current “lock-and-key” cannabis rules. More importantly, this would elevate the legal market over the illegal market by giving consumers something the black market never could: a legal and controlled place to consume.

That said, the specifics of how Ontario regulates consumption are key. Edibles and beverages should be available in any restaurant, bar, or clubs currently licensed to sell alcohol, as well as in stand-alone establishments dedicated solely to cannabis consumption. Ready access to legal consuming space is what can ultimately make the legal market more attractive than the alternative. The black market has always had various forms of edible cannabis available for sale but it has never offered a controlled and legal place for users to ingest or consume it. By liberalizing where it allows cannabis consumption the Ontario government can empower the legal and regulated market at the expense of illicit trade.

There are those who say cannabis and alcohol shouldn’t be mixed, and such behaviour shouldn’t be encouraged by allowing their sale in the same places. It’s true: people shouldn’t mix cannabis and alcohol. But that doesn’t mean these products shouldn’t be made available alongside each other, subject to appropriate regulation. Provincial certification programs could train servers both in the risks of combining alcohol and cannabis and in how to avoid abuse where possible. We already trust certified servers to understand the harms of alcohol intoxication and to cut customers off when they are intoxicated. It is not unreasonable to believe they can help enforce responsible consumption of cannabis.

In addition to commercial consumption, the province is also considering a special occasions permit (SOP) to accommodate cannabis consumption at concerts and outdoor festivals, to be used either separately or alongside an alcohol SOP. This should be reasonably simple to implement. Festivals would be able to offer their adult attendees a wider range of products, thus benefiting both vendors and future customers. As to smoking or vaping cannabis, festivals would be well within their rights to allow this in roped-off or age-restricted areas or wherever they currently allow tobacco use. Edibles and beverages could be sold alongside alcohol so long as the servers have the proper certification.

How do municipalities fit in? Ontario made the huge mistake of giving local city councillors veto rights on cannabis retail within their city limits. A city or town that opts out of cannabis retail obviously doesn’t mean consumers in those cities and towns can’t buy cannabis. It just pushes them back into the illegal market, which is precisely what we want to avoid.

Ontario should not make the same mistake with consumption. If a restaurant, bar, club or lounge can meet the provincial licensing required to sell edibles and beverages, it should be free to do so without busybody city councillors intruding into their business.

Green-lighting commercial cannabis consumption is the right thing to do. But the province must get it right. Competitive and consumer-friendly policies for commercial consumption would give consumers greater choice and convenience and help put a dent in the still-prevalent black market.

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Cannabis Conclave in Davos im Jahr 2020

Zum zweiten Mal in der Schweiz mit genauen Legalisierungsvorstellungen

2019 gab es eine Premiere auf dem Weltwirtschaftsforum in den Schweizer Gefilden um Davos. Menschen aus dem Cannabis-Business und Experten auf dem Gebiet luden zum geselligen Stelldichein ein und besprachen in exquisiter Atmosphäre die abgeschlossenen Entwicklungen und die Zukunft der Cannabis-Branche. Auch in diesem Jahr bot sich in Davos die Gelegenheit, mit den Geschäftemachern des speziellen Sektors und mit aufgeschlossenen Personen aus der Politik ins Gespräch zu kommen, um die Weichen für eine bessere Zukunft zu stellen. Dass es endlich an der Zeit für eine zeitgemäße Anpassung in der Drogen- und Gesundheitspolitik ist, bewies die Cannabis Conclave in Davos im Jahr 2020 erneut.

Auch im Jahr 2020 brachte die Cannabis Conclave verschiedene Führungskräfte der Cannabisindustrie, einige globale Investoren sowie politische Entscheidungsträger und internationale Medien zusammen, um die weltweite Legalisierungsdebatte – sowohl für Freizeit- als auch für medizinisches Cannabis – angemessen voranzutreiben und die wachsende Legitimität und Reife der legalen Cannabisindustrie hervorzuheben. Am 23. Januar fand das besondere Event statt, das unter anderem von dem North American Affairs Manager des Consumer Choice Center David Clement initiiert wurde. Im Gespräch mit dem Medical Cannabis Network gab Clement einige Details bekannt, die ihn zu seinem Engagement führten, welches er vor, während und nach den Tagen des Weltwirtschaftsforums benötigte und benötigen wird. „Sowohl auf internationaler als auch auf nationaler Ebene ist das Hauptproblem in der Thematik, dass die Gesetzgebung nicht auf Verbraucher oder Patienten ausgerichtet ist. Legalisierungsgesetze, ob im medizinischen Bereich oder bezüglich des Freizeitgebrauches, sollten immer den Zugang und die Erschwinglichkeit in den Vordergrund stellen. Leider ist dies in vielen Bereichen nicht der Fall. Es ist an der Zeit, dass internationale Gremien erkennen, dass der Krieg gegen Drogen ein Misserfolg ist, insbesondere wenn es um Cannabis geht. Ich denke, dass alle Länder in der Lage sein sollten, Cannabisvorschriften entsprechend ihren spezifischen Bedürfnissen zu erlassen. Trotzdem möchte ich alle Regierungen nachdrücklich ermutigen, den Krieg gegen Drogen aufzugeben und Cannabis zu legalisieren.“ Weiter führt David Clement an, dass es mehr Länder geben müsste, die sich dem Beispiel Kanadas annehmen und so zu einem internationalen Umschwung führen. „Die Legitimität der Branche kann dadurch gefestigt werden, dass weitere Länder die Legalisierung von Medizinalhanf und Freizeitgebrauch übernehmen. Kanada hat trotz seiner regulatorischen Fehler einen Kurs festgelegt, auf dem andere Länder diesem Beispiel folgen können. Wir sind zuversichtlich, dass in naher Zukunft ein Wendepunkt auf internationaler Ebene ansteht, wenn immer mehr Länder die Legalisierung übernehmen.“ Dass sich zumindest peu à peu etwas bewegt, ließ Clement dabei nicht unerwähnt. „Die großen Entwicklungen für Cannabis im Jahr 2020 werden neue Rechtsordnungen sein, die eine Legalisierung umfassen. Wir wissen, dass Luxemburg und Malta derzeit prüfen, wie ihr Legalisierungsprozess tatsächlich aussehen könnte. Ein großes Thema dieser beiden Länder ist die Frage, wie viel sie von Kanada lernen können. Wir hoffen beispielsweise, dass diese beiden Länder, obwohl sie die Legalisierung befürworten, eine Überregulierung von Cannabis vermeiden werden, wie sie in Kanada stattfand.“ Was er damit genau meint, führt der Affairs Manager des Consumer Choice Center auch an. „Nur durch patienten- und verbraucherfreundliche Vorschriften kann sichergestellt werden, dass die Legalisierung erfolgreich ist und der Schwarzmarkt verdrängt wird.“ Positiv wird David Clement auch dadurch gestimmt, dass die Welt nun mittlerweile ernsthaft zuhöre, wenn es um das Thema der Cannabislegalisierung geht – dies hätte ihm die Cannabis Conclave im Jahr 2020 in Davos bewiesen.

Der dort ebenfalls anwesende Stephen Murphy von Prohibition Partners sagte dazu in einem Interview mit Benzinga, dass es mit Cannabis erst jetzt vorangehe. Es fehlten derzeit noch die großen Marken auf dem Markt, sodass noch viel Platz für Teilnehmer übrig sei, die sich in dem vielversprechenden Geschäftsfeld versuchen wollen. Er betonte zudem, dass Cannabis zahlreiche Branchen abdeckt, darunter Getränke, Lebensmittel, Gesundheitswesen, Schönheitspflege, Wellness, Bauwesen, Textilien, Ingenieurwesen, Technologie, Tierpflege, Biokraftstoffe und sogar Bettwäsche. In den vergangenen drei Jahren, seitdem man seitens Prohibition Partners die Branche beobachte, habe dennoch bereits ein erstaunliches Wachstum stattgefunden, das nun weit über die damals fünf bis sechs existierenden Märkte reichen würde. Zudem gäbe es Hunderttausende von Menschen auf der ganzen Welt, die medizinisches Cannabis konsumierten, und man habe mittlerweile signifikante Beweise dafür, dass alleine diese Tatsache eine Umsetzung von neuen Gesetzen rechtfertige, sagte er. Man könne derzeit bestimmte Einstufungen benutzen, um den Zugang zu Cannabis in den unterschiedlichsten Ländern zu beschreiben. Es wäre daher eine sehr eingeschränkte und verzerrte Denkweise, wenn Menschen in Großbritannien verzweifelt an Cannabis zu medizinischen Zwecken gelangen wollten – dies aber nicht dürften, weil es von offizieller Stelle „nicht genug Daten“ gäbe – während in Israel und Kanada Personen damit schon lange behandelt werden. Immerhin habe man mittlerweile auch einen immer stärken Druck auf die unterschiedlichen Regulierungsbehörden feststellen können, welche allesamt eigene Gesetze, Richtlinien und Anträge zum Thema Cannabis besitzen. Es gäbe daher nun auch große Möglichkeiten für die Forschung und den allgemeinen Fortschritt, die die aktuell noch bestehenden großen Wissenslücken schrumpfen lassen könnten, welche global endlich unbedingt geschlossen werden müssten.

Legalize – worldwide!

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at consumerchoicecenter.org

Cannabis Conclave 2020 Dubbed The ‘Rebels Of Davos’

Last week, the Cannabis Conclave took place in Davos, Switzerland. The event was dubbed by some as the “rebellious side” of Davos.

The Conclave was hosted by the Consumer Choice Center and Prohibition Partners.

“The event featured industry leaders, investors and policy makers from over 25 different countries. The purpose of the event is to continue to fuel the legalization debate internationally,” David Clement, North American Affairs Manager at Consumer Choice Center, told Benzinga.

Legalizing Cannabis

“Fueling the legalization debate, and the advancement of legalization, requires three things,” Clement said. “First, we need policy makers who are open to the idea, and who realize that the war on drugs is failing. Second, we need entrepreneurs who want to enter the legal space and meet the demand of consumers and patients.”

Clement said the industry needs investors to help catapult it forward so it can expand, and ultimately stamp out the black market.

“That is why we bring those three groups together in Davos. One headline called us the ‘Rebels of Davos,’ explaining that the Cannabis Conclave is the sharper, more daring edge of what goes on during the World Economic Forum,” Clement said.

The team is committed to returning in 2021.

Listen to Yaël Ossowski and Clement on Consumer Choice Radio discuss the Cannabis Conclave further here: https://consumerchoicecenter.org/radio/ep3/

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at 
consumerchoicecenter.org

Davos cannabis conclave advances cause for legalisation

The second annual, premier cannabis industry event – the Cannabis Conclave – returned to Davos this January to bring together industry leaders and policy makers.

This year the Cannabis Conclave brought together cannabis industry executives, global investors, policy makers and international media to fuel the legalisation debate globally, both for recreational and medical cannabis, and to highlight the growing legitimacy and maturity of the legal cannabis industry.

The Consumer Choice Center organised the event that took place in Davos, Switzerland on 23 January, 2020.

Medical Cannabis Network spoke to organiser, David Clement, to find out more.

Cannabis Conclave 2020

As the world’s most influential executives, activists, and change makers descend on Davos, the conclave aimed to bring cannabis to the front and centre of the global discussion.

Clement, North American Affairs Manager with the Consumer Choice Center, said: “Both internationally and domestically, the number one issue is that legislation is not consumer or patient focussed. Legalisation bills, whether medical or recreational, should always be putting access and affordability first. Unfortunately, in many instances this is not the case. It is time for international bodies to realise that the war on drugs is a failure, especially its focus on cannabis.

“I think that countries should be able to craft cannabis regulations to suit their specifics needs. That being said, I’d strongly encourage all governments to abandon the war on drugs and to legalise cannabis.”

The high-end networking that occurs at the conclave ensures the right amount of knowledge sharing for future collaborations, and for smarter consumer focussed policy.

Clements said: “The legitimacy of the industry can be cemented by having additional countries embrace medical and recreational legalisation. Canada, despite its regulatory mistakes, has charted a course for other countries to follow their lead. We are hopeful that as more countries adopt legalisation, that a tipping point internationally is in the near future.”

Cannabis in 2020

2020 has been earmarked as a big year for cannabis – with expectations that both recreational and medicinal cannabis will become much more ‘normalised’.

Clements said: “The big developments for cannabis in 2020 will be new jurisdictions embracing legalisation. We know that Luxembourg and Malta are now currently reviewing what their legalisation process could look like. One big theme from those two countries is the question of how much they will learn from Canada? For example, it is our hope that while embracing legalisation that those two countries avoid over-regulating cannabis like Canada did.

“Having patient friendly and consumer friendly regulations is the only way to ensure that legalisati on is a success, and that the black market is stamped out.”

He added: “One big takeaway from Cannabis Conclave 2020 is that the world is now listening when it comes to cannabis legalisation.”

Originally published here.


The Consumer Choice Center is the consumer advocacy group supporting lifestyle freedom, innovation, privacy, science, and consumer choice. The main policy areas we focus on are digital, mobility, lifestyle & consumer goods, and health & science.

The CCC represents consumers in over 100 countries across the globe. We closely monitor regulatory trends in Ottawa, Washington, Brussels, Geneva and other hotspots of regulation and inform and activate consumers to fight for #ConsumerChoice. Learn more at 
consumerchoicecenter.org

NOBL Completes Series A Funding Round At Davos, Altitude Investment Management Among Round Participants

Cannabis data and consulting company NOBL said Thursday it finalized its Series A fundraise at Davos and capital support of £1.25 million ($1.64 million).

Altitude Investment Management, Enexis AB and Artemis Growth Partners are some of the dominant cannabis investors who have supported the round.

Closing our Series A with the caliber of investors we’ve brought in is indicative of our performance and reputation. We are proven to understand global markets, launch sector leading brands and operate tenacious companies that deliver month on month revenue growth” Co-Founder, Stephen Murphy, said in a statement at NOBL’s co-hosted Cannabis Conclave event in Davos.

NOBL offers a portfolio platform that contains some of the leading companies and brands in the industry, such as Atalis, European Cannabis Weeks, Prohibition Partners, NOBL Live and Cannabis Europa.

“We will continue to invest in talent and innovation while also enabling our operating companies to make smarter and more effective business decisions that will shape the future of the global cannabis industry in a meaningful and impactful way,” Murphy said.

Michael Goldberg, Partner at Altitude Investment Management, stated, “We have been collaborating with the team at NOBL over the last two years and are pleased to invest in this financing round as NOBL continues to shape the future of global cannabis through knowledge and intelligence with its superior data, insights, and networking opportunities.”

Scroll to top